Biography:Kathy Giusti

From HandWiki
Kathy Giusti
GiustiKG (cropped).jpg
Kathy Giusti in 2021
Born1958
EducationBachelor of Science in Nursing
Alma mater
Occupation
  • Co-founder, Multiple Myeloma Research Foundation (MMRF)
  • Co-chair, Harvard Business School (HBS) Kraft Precision Medicine Accelerator
Spouse(s)Paul Giusti
Children2

Kathy Giusti is a business leader and a healthcare disrupter.[1] She is a two-time cancer survivor having been diagnosed with multiple myeloma and breast cancer. Kathy Co-Founded the Multiple Myeloma Research Foundation (the MMRF) where she served as CEO and president for nearly two decades.[2] She also co-chaired the Harvard Business School (HBS) Kraft Precision Medicine Accelerator,[3] which she helped found, as a Senior Fellow at Harvard Business School.[4]

Kathy is recognized as a pioneer in precision medicine,[4] having seen its vast potential in oncology and other diseases. She uses her patient experience and business acumen to drive science faster with innovative business models across registries, big data, clinical trials, and venture. Kathy is a champion of patient engagement, encouraging each patient take initiative to optimize their own care.[5]

Kathy has been named one of Time (magazine) magazine's 100 Most Influential People in the world.[6] and ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders.[7]

Career

Early career

Kathy held executive positions with increasing responsibility in consumer marketing with Gillette/Procter & Gamble and in the pharmaceutical sector of the healthcare industry with Merck & Co. and G.D. Searle & Company (now Pfizer).[8]

The Multiple Myeloma Research Foundation

In 1998, with her identical twin sister Karen Andrews, Kathy Founded the Multiple Myeloma Research Foundation (the MMRF). The MMRF’s mission is to accelerate a cure for each and every multiple myeloma patient.

As founder, president, CEO, and Chief Mission Officer Kathy has led the MMRF in establishing partnerships and collaborative research models in precision medicine including the Multiple Myeloma Research Consortium (MMRC), the MMRF CoMMpass™ study,[9] CureCloud, the Right Track, and the Myeloma Investment Fund.[10][11][12]

Under Giusti the MMRF has raised more than $500 million to fund research, 15 drugs have been approved to treat multiple myeloma, and many clinical trials are underway.[13] These efforts have accelerated the pace at which treatments are brought to patients and more than tripled patients' survival.[1]

Harvard Business School (HBS)

Giusti joined the Harvard Business School faculty as Senior Fellow, Co-Chairing the HBS Kraft Precision Medicine Accelerator, a $20 million endowed program provided by Robert Kraft and the Kraft Family Foundation.[3]

The Kraft Accelerator has convened more than 300 leaders from throughout the healthcare and precision medicine ecosystem, from different disease states, and from the investment community. The Kraft Accelerator has identified and published best practices for accelerating cures and created The Kraft Precision Medicine Accelerator Playbook for Cures.[14]

Giusti has co-led the formation of the Kraft Accelerator Leadership Forum, a group of CEOs from disease-focused foundations working together to address the most important challenges, share best practices, and accelerate precision medicine models.  

Diagnosis

In 1996, Kathy Giusti was diagnosed with multiple myeloma, an incurable blood cancer. When diagnosed, Giusti was 37 years old and was given three years to live. At the time of her diagnosis, there were no new treatments in the pipeline for multiple myeloma.[15] In 2022, Kathy was diagnosed with early-stage breast cancer as well.[16]

Appointments

Kathy has been appointed to multiple positions and advisory boards, all with a focus on developing cures for cancer. These include:

  • National Cancer Advisory Board (NCAB). Appointed by President George W. Bush. Served for six years during the Bush and Obama administrations.[9]
  • Precision Medicine Initiative (PMI) Working Group, appointed by President Obama[17]
  • Biden Cancer Initiative Advisory Committee and Biden Moonshot
  • National Institutes of Health All of US Research Program[17]
  • Faster Cures Advisory Board Changemakers[18]
  • Verily Advisory Board[19]
  • IMS Board[20]
  • EQRx Board[21]

Recognition

Giusti has received numerous awards for her leadership:  

  • Named one of Time (magazine) magazine's 100 Most Influential People in the world
  • Ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders
  • Recognized as 1 of 34 leaders changing healthcare by Fortune magazine[22]
  • Named an Open Science Champion of Change by the White House[23]
  • Presented the Harvard Business School Alumni Achievement Award[24]
  • Received the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition.[25]
  • Presented the 2021 American Association for Cancer Research Distinguished Public Service Award[26]
  • Named the Healthcare Businesswomen's Association's Woman of the Year Award[27]

In the Press

Kathy has been featured in multiple business, healthcare, and mainstream publications:

Podcasts

Kathy has been invited to participate in multiple business, healthcare, and patient-focused podcasts:

Publications

Kathy has authored or co-authored multiple articles in business, consumer, and scientific publications:

References

  1. ↑ 1.0 1.1 1.2 "These 3 Former Business Leaders Are Disrupting Medicine" (in en). https://fortune.com/2016/04/22/business-disrupting-medicine-kathy-giusti-bill-gates-michael-milken/. 
  2. ↑ "About the Multiple Myeloma Research Foundation | The MMRF" (in en-US). https://themmrf.org/about/. 
  3. ↑ 3.0 3.1 "Kraft Accelerator - Harvard Business School". https://www.hbs.edu/kraft-accelerator/hear-our-mission.html. 
  4. ↑ 4.0 4.1 "Story Details - Alumni - Harvard Business School". 24 October 2016. https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=5871. 
  5. ↑ "Harvard Business Publishing Education". https://hbsp.harvard.edu/product/814026-PDF-ENG?Ntt=mmrf&itemFindingMethod=Search. 
  6. ↑ Couric, Katie (2011-04-21). "The 2011 TIME 100 - TIME" (in en-US). Time. ISSN 0040-781X. http://content.time.com/time/specials/packages/article/0,28804,2066367_2066369_2066321,00.html. Retrieved 2021-02-19. 
  7. ↑ "UVM Alumna Kathy Giusti Named One of Fortune Magazine's 'World's 50 Greatest Leaders'" (in en). https://www.uvm.edu/uvmnews/news/uvm-alumna-kathy-giusti-named-one-fortune-magazines-worlds-50-greatest-leaders. 
  8. ↑ Giusti, Kathy (Feb 17, 2021). "Kathy Giusti LinkedIn". https://www.linkedin.com/in/kathygiusti/. 
  9. ↑ 9.0 9.1 "Story Details - Alumni - Harvard Business School". 24 April 2014. https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=3396. 
  10. ↑ MMRF (2020-07-14). "MMRF Launches CureCloud to Democratize Healthcare for Cancer Patients" (in en-US). https://themmrf.org/2020/07/14/mmrf-launches-curecloud-to-democratize-healthcare-for-cancer-patients/. 
  11. ↑ 11.0 11.1 "4 Important Steps to Take After a Cancer Diagnosis". Time. 12 February 2019. https://time.com/5525656/cancer-diagnosis-what-to-do/. Retrieved 2021-02-19. 
  12. ↑ MMRF (2019-04-23). "Multiple Myeloma Research Foundation (MMRF) Launches Innovative Fund to Accelerate New Myeloma Treatments" (in en-US). https://themmrf.org/2019/04/23/multiple-myeloma-research-foundation-mmrf-launches-innovative-fund-to-accelerate-new-myeloma-treatments/. 
  13. ↑ MMRF (2020-12-04). "The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients" (in en-US). https://themmrf.org/2020/12/04/the-mmrf-drives-unparalleled-advances-for-multiple-myeloma-patients/. 
  14. ↑ "Kraft Accelerator - Harvard Business School". https://www.hbs.edu/kraft-accelerator/use-the-tools.html. 
  15. ↑ 15.0 15.1 Kincaid, Ellie. "She Was Given Three Years To Live. So She Transformed Cancer Research" (in en). https://www.forbes.com/sites/elliekincaid/2018/03/26/cancers-transformer/. 
  16. ↑ Giusti, Kathy (17 June 2022). "I've Been Diagnosed With Two Different Cancers—This Is What I've Learned" (in en). https://www.prevention.com/health/a40187689/kathy-giusti-cancer/. 
  17. ↑ 17.0 17.1 "Kathy Giusti, M.B.A." (in en). 2020-08-27. https://allofus.nih.gov/about/who-we-are/pmi-working-group-advisory-committee-director/kathy-giusti-mba. 
  18. ↑ "FasterCures Changemakers: Disruptive Philanthropy for Patients" (in en). https://milkeninstitute.org/centers/fastercures/fastercures-changemakers-disruptive-philanthropy-for-patients. 
  19. ↑ "Leadership | Verily Life Sciences" (in en). https://verily.com/our-story/leadership/. 
  20. ↑ "Multiple Myeloma Research Foundation (MMRF) Founder, CEO Receives American Society of Clinical Oncology's Partners In Progress Award" (in en-US). https://www.biospace.com/article/multiple-myeloma-research-foundation-mmrf-founder-ceo-receives-american-society-of-clinical-oncology-s-partners-in-progress-award-/. 
  21. ↑ "EQRx Appoints Kathy Giusti to Board of Directors" (in en). 2021-09-27. https://www.eqrx.com/press-release/eqrx-appoints-kathy-giusti-to-board-of-directors/. 
  22. ↑ "34 Leaders Who Are Changing Health Care" (in en). https://fortune.com/2017/04/20/digital-health-care-leaders/. 
  23. ↑ "Democratizing the Science, Accelerating the Cure" (in en). 2013-06-20. https://obamawhitehouse.archives.gov/blog/2013/06/20/democratizing-science-accelerating-cure. 
  24. ↑ "Story Details - Alumni - Harvard Business School". January 2009. https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=1988. 
  25. ↑ "Personalized Medicine Coalition - Advocates for precision medicine : PMC Press Releases : Press Releases : Personalized Medicine Coalition Recognizes Kathy Giusti with Award for Leadership" (in en). http://www.personalizedmedicinecoalition.org/News/Press_Releases/Personalized_Medicine_Coalition_Recognizes_Kathy_Giusti_with_Award_for_Leadership. 
  26. ↑ "Giusti, Pelosi, and Sawyers to Receive American Association for Cancer Research Distinguished Public Service Awards | AACR | News Releases" (in en). https://www.aacr.org/about-the-aacr/newsroom/news-releases/giusti-pelosi-and-sawyers-to-receive-american-association-for-cancer-research-distinguished-public-service-awards/. 
  27. ↑ "Woman of the Year Past Recipients | HBA". https://www.hbanet.org/woman-of-the-year-past-recipients. 
  28. ↑ Woodruff, Lee. "HTwin Sister Caregivers Team Up to Fight Cancer and Help Millions Along the Way". https://www.aarp.org/caregiving/basics/info-2022/twin-caregivers-fight-cancer.html. 
  29. ↑ Giusti, Kathy (17 June 2022). "HI've Been Diagnosed With Two Different Cancers—This Is What I've Learned". https://www.prevention.com/health/a40187689/kathy-giusti-cancer/. 
  30. ↑ Giusti, Kathy (12 April 2022). "How to reduce racial disparities in cancer". https://thehill.com/opinion/healthcare/3265475-how-to-reduce-racial-disparities-in-cancer/. 
  31. ↑ Giusti, Kathy. "How One Woman Used Her Multiple Myeloma Diagnosis to Fuel the Search for a Cure". https://www.health.com/condition/cancer/wellness-warriors-kathy-giusti-multiple-myeloma. 
  32. ↑ Giusti, Kathy. "acial gaps persist in cancer care — here's how we can close them". https://thehill.com/opinion/healthcare/590677-racial-gaps-persist-in-cancer-care-heres-how-we-can-close-them. 
  33. ↑ Giusti, Opinion by Kathy (19 October 2021). "Opinion: Colin Powell showed that even the bravest are vulnerable". https://www.cnn.com/2021/10/19/opinions/colin-powell-multiple-myeloma-covid-guisti/index.html. 
  34. ↑ Todd, Deborah (2021-10-05). "50 years later, women still lead the charge in the fight against cancer" (in en). https://thehill.com/opinion/healthcare/575411-50-years-later-women-still-lead-the-charge-in-the-fight-against-cancer. 
  35. ↑ Giusti, Kathy (2021-06-30). "Kathy Giusti: Warp Speed to cancer cures – COVID vaccine should be our model to save more lives" (in en-US). https://www.foxnews.com/opinion/cancer-cure-warp-speed-covid-vaccines-kathy-giusti. 
  36. ↑ "Reuters Events: Digital Health" (in English). https://reutersevents.com/events/digital-health/. 
  37. ↑ Giusti, Opinion by Kathy (24 February 2021). "Opinion: What Covid can teach us about cancer". https://www.cnn.com/2021/02/24/opinions/covid-lessons-for-cancer-opinion-giusti/index.html. 
  38. ↑ Wolfe, Alexandra (2018-05-25). "An Urgent Mission to Speed Progress Against Cancer" (in en-US). The Wall Street Journal. ISSN 0099-9660. https://www.wsj.com/articles/an-urgent-mission-to-speed-progress-against-cancer-1527260815. 
  39. ↑ Marcus, Amy Dockser (2015-09-28). "How One Family Faced Difficult Decisions About DNA Sequencing" (in en-US). The Wall Street Journal. ISSN 0099-9660. https://www.wsj.com/articles/how-one-family-faced-difficult-decisions-about-dna-sequencing-1443406974. 
  40. ↑ Bryant, Adam (2016-10-07). "Kathy Giusti: Sharing Life Lessons From a Death Sentence (Published 2016)" (in en-US). The New York Times. ISSN 0362-4331. https://www.nytimes.com/2016/10/09/business/kathy-giusti-sharing-life-lessons-from-a-death-sentence.html. 
  41. ↑ Quintanilla, Carl. "The Money Chase: Harvard Business School". CNBC. https://www.cnbc.com/money-chase-inside-harvard-business-school/. 
  42. ↑ M+A (2020-05-22). "Managing Through Crisis: Why Urgency Can Bring Clarity" (in en). https://www.kathygiusti.com/latest/publications-and-articles/324/managing-through-crisis-why-urgency-can-bring-clarity. 
  43. ↑ M+A (2020-04-29). "Kathy Giusti on Everyone Talks to Liz Claman" (in en). https://www.kathygiusti.com/uncategorized/313/kathy-giusti-on-everyone-talks-to-liz-claman. 
  44. ↑ M+A (2020-03-09). "Kathy Giusti on Better Together with Maria Menounos" (in en). https://www.kathygiusti.com/uncategorized/308/kathy-giusti-on-better-together-with-maria-menounos. 
  45. ↑ "Kathy Giusti" (in en-US). https://www.pharmavoice.com/wow-podcasts/wow-kathy-giusti/. 
  46. ↑ "#44: Kathy Giusti, Cancer Fighter and Health Care Revolutionary - No Limits with Rebecca Jarvis" (in en). https://www.iheart.com/podcast/187-no-limits-with-rebecca-jar-29418771/episode/44-kathy-giusti-cancer-fighter-and-59512634/. 
  47. ↑ "Reducing Racial Disparities in Cancer Treatment Demands Collective Action". Harvard Business Review. 2022-06-13. https://hbr.org/2022/06/reducing-racial-disparities-in-cancer-treatment-demands-collective-action. 
  48. ↑ "Reducing Racial Disparities in Cancer Outcomes". Harvard Business Review. 2022-01-17. https://hbr.org/2022/01/reducing-racial-disparities-in-cancer-outcomes. 
  49. ↑ "Addressing Demographic Disparities in Clinical Trials". Harvard Business Review. 2021-06-11. ISSN 0017-8012. https://hbr.org/2021/06/addressing-demographic-disparities-in-clinical-trials. 
  50. ↑ "A New Playbook for Cure-Seeking Nonprofits" (in en-us). https://www.thejournalofprecisionmedicine.com/a-new-playbook-for-cure-seeking-nonprofits/. 
  51. ↑ "How Nonprofit Foundations Can Sustainably Fund Disease Research". Harvard Business Review. 2020-09-30. ISSN 0017-8012. https://hbr.org/2020/09/how-nonprofit-foundations-can-sustainably-fund-disease-research. 
  52. ↑ "What It Takes to Lead a Disease Research Foundation". Harvard Business Review. 2020-08-18. ISSN 0017-8012. https://hbr.org/2020/08/what-it-takes-to-lead-a-disease-research-foundation. 
  53. ↑ "How Medical Nonprofits Set Winning Strategy". Harvard Business Review. 2020-03-06. ISSN 0017-8012. https://hbr.org/2020/03/how-medical-nonprofits-set-winning-strategy. 
  54. ↑ "One Obstacle to Curing Cancer: Patient Data Isn't Shared". Harvard Business Review. 2016-11-28. ISSN 0017-8012. https://hbr.org/2016/11/one-obstacle-to-curing-cancer-patient-data-isnt-shared. 
  55. ↑ "What Cancer Researchers Can Learn from Direct-to-Consumer Companies". Harvard Business Review. 2017-01-12. ISSN 0017-8012. https://hbr.org/2017/01/what-cancer-researchers-can-learn-from-direct-to-consumer-companies. 
  56. ↑ Giusti, Kathy; Young, Anne Quinn; Lehrhaupt, Kerri (May–June 2018). "Closing Knowledge Gaps to Optimize Patient Outcomes and Advance Precision Medicine". Cancer Journal (Sudbury, Mass.) 24 (3): 144–151. doi:10.1097/PPO.0000000000000319. ISSN 1540-336X. PMID 29794540. https://pubmed.ncbi.nlm.nih.gov/29794540/. 
  57. ↑ Giusti, Kathy; Young, Anne Quinn; Winget, Melissa; Lehrhaupt, and Kerri (2017-04-11). "Understanding Differences in Critical Decisions in the Multiple Myeloma Patient Journey in the Era of Precision Medicine". American Journal of Hematology/Oncology 13 (3). https://www.gotoper.com/publications/ajho/2017/2017mar/understanding-differences-in-critical-decisions-in-the-multiple-myeloma-patient-journey-in-the-era-of-precision-medicine. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Biography:Kathy_Giusti&oldid=3440281"